首页> 外国专利> Use of a synthetic retinal derivative for the preparation of a medicament for the treatment or prevention of age-related retinal dysfunction or improving rhodopsin regeneration ratio in a human subject

Use of a synthetic retinal derivative for the preparation of a medicament for the treatment or prevention of age-related retinal dysfunction or improving rhodopsin regeneration ratio in a human subject

机译:合成的视网膜衍生物在制备用于治疗或预防人类受试者中年龄相关性视网膜功能障碍或改善视紫红质再生率的药物中的用途

摘要

A method of treating or preventing age-related retinal dysfunction involves administering to a patient a pharmaceutically effective amount of a synthetic retinal derivative repeatedly over a duration of at least about 3 months. Effective synthetic retinal derivatives include 9-cis-retinyl esters, 11-cis-retinyl esters, derivatives and congeners thereof, and combinations thereof. Suitable ester substituents include carboxylates of C1-C10 monocarboxylic acids and C2-C22 polycarboxylic acids.
机译:一种治疗或预​​防与年龄有关的视网膜功能障碍的方法,涉及在至少约3个月的时间内反复向患者给药药学有效量的合成视网膜衍生物。有效的合成视网膜衍生物包括9-顺-视黄基酯,11-顺-视黄基酯,其衍生物和同类物及其组合。合适的酯取代基包括C 1 -C 10一元羧酸和C 2 -C 22多元羧酸的羧酸盐。

著录项

  • 公开/公告号IL258356D0

    专利类型

  • 公开/公告日2018-05-31

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF WASHINGTON;

    申请/专利号IL20180258356

  • 发明设计人

    申请日2018-03-26

  • 分类号A61K;

  • 国家 IL

  • 入库时间 2022-08-21 12:52:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号